Bank of Montreal
AKRO

Bank of Montreal’s Akero Therapeutics AKRO Stock Holding History

Bank of Montreal’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-69,653
Closed -$769 – 4046
2022
Q2 		$769 Buy
+69,653
New +$726K ﹤0.01% 2470
2021
Q2 		– Sell
-385
Closed -$11K – 3661
2021
Q1 		$11K Sell
385
-1,714
-82% -$51.9K ﹤0.01% 4309
2020
Q4 		$60K Buy
2,099
+1,472
+235% +$40.9K ﹤0.01% 3855
2020
Q3 		$18K Sell
627
-269
-30% -$9.4K ﹤0.01% 3876
2020
Q2 		$36K Buy
+896
New +$20.5K ﹤0.01% 3581
2020
Q1 		– Sell
-10,625
Closed -$236K – 4059
2019
Q4 		$236K Buy
10,625
+207
+2% +$4.28K ﹤0.01% 3076
2019
Q3 		$238K Buy
+10,418
New +$242K ﹤0.01% 2804

Other funds holding AKRO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ST
Skorpios Trust Limassol, Cyprus $53.2M AUM 90.96% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Bank of Montreal's AKRO Position: Q3 2022 in Review

Bank of Montreal sold out of Akero Therapeutics (AKRO) in Q3 2022, closing a stake of 69,653 shares — an estimated $769 sold.

Bank of Montreal first reported a position in AKRO in Q3 2019 and held it in 7 quarters. The position peaked at $238K in Q3 2019. 146 funds tracked by Wall St. Rank hold AKRO as of Q3 2022.

  • Bank of Montreal reported no remaining Akero Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Bank of Montreal sold 69,653 Akero Therapeutics shares in Q3 2022, an estimated $769.
  • Bank of Montreal first reported a position in Akero Therapeutics in Q3 2019 and held it in 7 quarters.
  • Bank of Montreal's Akero Therapeutics position peaked at $238K in Q3 2019.
  • 146 funds tracked by Wall St. Rank held Akero Therapeutics as of Q3 2022.

Based on Bank of Montreal's 13F filing for Q3 2022, filed 10 Nov 2022.